Publication Date
| In 2025 | 0 |
| Since 2024 | 0 |
| Since 2021 (last 5 years) | 0 |
| Since 2016 (last 10 years) | 0 |
| Since 2006 (last 20 years) | 1 |
Descriptor
| Adolescents | 1 |
| Autism | 1 |
| Children | 1 |
| Drug Therapy | 1 |
| Federal Programs | 1 |
| Health Services | 1 |
| Individual Characteristics | 1 |
| Low Income Groups | 1 |
| Measures (Individuals) | 1 |
| Pervasive Developmental… | 1 |
Source
| Autism: The International… | 1 |
Publication Type
| Journal Articles | 1 |
| Reports - Research | 1 |
Education Level
Audience
Location
| Colorado | 1 |
| Delaware | 1 |
| District of Columbia | 1 |
| Michigan | 1 |
| Montana | 1 |
| North Dakota | 1 |
| Ohio | 1 |
| South Dakota | 1 |
| Tennessee | 1 |
| Utah | 1 |
| Washington | 1 |
| More ▼ | |
Laws, Policies, & Programs
Assessments and Surveys
What Works Clearinghouse Rating
Peer reviewed
Direct linkSchubart, Jane R.; Camacho, Fabian; Leslie, Douglas – Autism: The International Journal of Research and Practice, 2014
This study characterized psychotropic medication use among Medicaid-enrolled children and adolescents with autism spectrum disorders by examining trends over time, including length of treatment and polypharmacy using 4 years of administrative claims data from 41 state Medicaid programs (2000-2003). The data set included nearly 3 million children…
Descriptors: Children, Adolescents, Pervasive Developmental Disorders, Autism
